Multiple outlets report renewed interest in nattō, a traditional Japanese fermented soybean food, as a potential “superfood” that may help lower blood pressure. Coverage claims the food contains bioactive compounds that could support cardiovascular health, presented as a more “natural” approach compared with conventional strategies.
At the same time, the articles caution that nattō is not risk-free. Reporting highlights potential downsides and encourages consumers to consider safety factors rather than relying on the food alone. The tone in the provided excerpts emphasizes nattō’s distinctive characteristics—described as strongly scented and polarizing—alongside warnings about possible harms depending on individual health conditions.
Across the outlets, the main difference is framing: one focuses on the broad promise of blood-pressure benefits and the novelty of the trend, while also stressing risks; both excerpts use similar language and do not provide detailed clinical data in the text shown. Overall, the story centers on the claim of possible benefits paired with reminders that further consideration is needed before using nattō for health purposes.
